Advances in the mechanism of action of metformin in pituitary tumors

doi:10.13105/wjma.v11.i5.144

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2252)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

WORD

HTML

1329

Figures (1-1)

245

Sum=1676

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

167

Download

353

Sum=520

Jun 18, 2023 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Meta-Anal. Jun 18, 2023; 11(5): 144-150
Published online Jun 18, 2023. doi: 10.13105/wjma.v11.i5.144

Open in New Tab Full Size Figure Download Figure

Figure 1 Potential mechanisms of metformin in the treatment of pituitary tumors. AMPK: Adenosine monophosphate activated protein kinase; ATF: Activating transcription factor; AKT: Protein kinase B; BAX: Bcl-associated X, IGF: Insulin-like growth factor; mTOR: Mammalian target of rapamycin.

Citation: Zhang LY, Yin YH, Wang XJ. Advances in the mechanism of action of metformin in pituitary tumors. World J Meta-Anal 2023; 11(5): 144-150
URL: https://www.wjgnet.com/2308-3840/full/v11/i5/144.htm
DOI: https://dx.doi.org/10.13105/wjma.v11.i5.144